Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost-Effectiveness and Budget Impact Analysis of Primary Screening With Human Papillomavirus Test With Genotyping in Argentina.

Value in health regional issues - 1 Dec 2021

Garay Osvaldo Ulises, Maritano Furcada Joaquín, Ayerbe Francisco, Pena Requejo Rave Ramiro A, Tatti Silvio Alejandro

Abstract excerpt

OBJECTIVES: Cervical cancer (ICC) is the fourth leading cause of mortality in women in Argentina and primary screening with conventional cytology (Papanicolaou smear) is the most widely used strategy despite its limitations. Strategies based on human papillomavirus (HPV) testing have the potential to improve detection and reduce mortality. The objective of this study is to evaluate the cost-effectiveness and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alphapapillomavirus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Argentina

Share to Cost-Benefit Analysis

Share to Genotype

Share to Papillomaviridae

Source

Identifiers

PMID: 34530292
DOI: 10.1016/j.vhri.2021.07.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost-Effectiveness and Budget Impact Analysis of Primary Screening With Human Papillomavirus Test With Genotyping in Argentina.PMID 34530292Read ↗

The budget impact of cervical cancer screening using HPV primary screening.Semantic proximity Read ↗

Benefits, harms and cost-effectiveness of cervical screening and treatment in 78 low-income and lower-middle income countries for women in the general population: modelling to support updated WHO cervical screening and treatment guidelines to prevent cervical cancerSemantic proximity Read ↗

Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile.Semantic proximity Read ↗

The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis.Semantic proximity Read ↗

The Potential Clinical and Economic Value of a Human Papillomavirus Primary Screening Test That Additionally Identifies Genotypes 31, 45, 51, and 52 Individually.Semantic proximity Read ↗

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.Semantic proximity Read ↗

Cost-effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV-positive women in cervical cancer screening.Semantic proximity Read ↗

Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia.Semantic proximity Read ↗

Cost Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16, 18 VaccinationSemantic proximity Read ↗

Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer ScreeningSemantic proximity Read ↗

Cost-Effectiveness Analysis of Genomic Profiling in Early Breast Cancer in ColombiaSemantic proximity Read ↗

Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.